Olema Pharmaceuticals, Inc.
NASDAQ:OLMA
4.67 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 139.48 | 68.539 | 23.702 | 287.25 | 338.549 | 0.068 | 3.149 |
| Short Term Investments
| 294.606 | 193.268 | 180.719 | 273.438 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 434.086 | 261.807 | 204.421 | 287.25 | 338.549 | 0.068 | 3.149 |
| Net Receivables
| 2.12 | 0.673 | 0.319 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | -0.319 | -0.353 | 0 | 0 | 0 |
| Other Current Assets
| 2.267 | 4.033 | 4.159 | 3.305 | 3.588 | 0.035 | 0.093 |
| Total Current Assets
| 438.473 | 266.513 | 208.899 | 287.25 | 342.137 | 0.103 | 3.242 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 1.314 | 3.259 | 3.975 | 4.72 | 0.075 | 0.026 | 0.026 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 11.192 | 7.173 | 2.771 | 3.975 | 0.51 | 0.003 | 0.003 |
| Total Non-Current Assets
| 12.506 | 10.432 | 6.746 | 8.695 | 0.585 | 0.029 | 0.029 |
| Total Assets
| 450.979 | 276.945 | 215.645 | 295.945 | 342.722 | 0.132 | 3.271 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 4.46 | 2.698 | 0.374 | 0.023 | 0.719 | 0.935 | 0.116 |
| Short Term Debt
| 1.172 | 0.988 | 1.015 | 1.862 | 0 | 0 | 0 |
| Tax Payables
| 0.041 | 0.073 | 0.067 | 0.088 | 0.642 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 7.687 | 0 | 0 | 0 |
| Other Current Liabilities
| 36.085 | 17.862 | 15.093 | 7.046 | 3.224 | 0.443 | 0.085 |
| Total Current Liabilities
| 41.758 | 21.621 | 16.549 | 9.019 | 4.585 | 1.378 | 0.201 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0 | 1.429 | 1.55 | 2.358 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 9.348 |
| Total Non-Current Liabilities
| 0.257 | 1.429 | 1.55 | 2.357 | 0 | 9.348 | 9.348 |
| Total Liabilities
| 42.015 | 23.05 | 18.099 | 11.376 | 4.585 | 10.726 | 9.549 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 342.722 | 9.348 | 9.348 |
| Common Stock
| 0.006 | 0.004 | 0.003 | 0.003 | 0.003 | 0.001 | 0.001 |
| Retained Earnings
| -435.106 | -305.632 | -208.977 | -104.19 | -33.094 | -10.762 | -6.446 |
| Accumulated Other Comprehensive Income/Loss
| 0.143 | 0.347 | -1.813 | -0.149 | -342.722 | -9.349 | -0.071 |
| Other Total Stockholders Equity
| 843.921 | 559.176 | 408.333 | 388.904 | 713.95 | 9.517 | 0.238 |
| Total Shareholders Equity
| 408.964 | 253.895 | 197.546 | 284.569 | 338.137 | -10.594 | -6.278 |
| Total Equity
| 408.964 | 253.895 | 197.546 | 284.569 | 338.137 | -10.594 | -6.278 |
| Total Liabilities & Shareholders Equity
| 450.979 | 276.945 | 215.645 | 295.945 | 342.722 | 0.132 | 3.271 |